Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Kathi Vidal"


3 mentions found


(Reuters) - A U.S. Patent Office tribunal ruled for Intel Corp on Tuesday on the chipmaking giant’s bid to invalidate a patent that represented $1.5 billion of a $2.18 billion verdict it lost to VLSI Technology LLC in 2021. REUTERS/Dado Ruvic/Illustration/file photoThe Patent Trial and Appeal Board invalidated the computer chip-related patent after canceling another VLSI patent that accounted for the remainder of the Texas federal court verdict last month. A jury ruled for Intel in 2021 in another Texas patent case in which VLSI had sought $3.1 billion in damages. The patent board proceeding decided on Tuesday was initiated by South Dakota-based Patent Quality Assurance LLC. The case is Patent Quality Assurance LLC v. VLSI Technology LLC, Patent Trial and Appeal Board, No.
Persons: Dado Ruvic, Kathi Vidal, OpenSky, Benjamin Fernandez, Wilmer Cutler Pickering Hale, Dorr, Bruce Slayden, Slayden Grubert, Babak, Kenneth Weatherwax, Weatherwax Read Organizations: Reuters, U.S . Patent, Intel Corp, VLSI Technology, REUTERS, U.S ., Appeals, Federal Circuit, Intel, SoftBank Group Corp, Fortress Investment Group, Assurance, OpenSky Industries, Lowenstein, Tech Locations: Texas, Delaware, Northern California, South Dakota
The Patent Trial and Appeal Board invalidated the computer chip-related patent after canceling another VLSI patent that accounted for the remainder of the Texas federal court verdict last month. A jury ruled for Intel in 2021 in another Texas patent case in which VLSI had sought $3.1 billion in damages. The patent board proceeding decided on Tuesday was initiated by South Dakota-based Patent Quality Assurance LLC. An attorney for Patent Quality Assurance did not immediately respond to a request for comment. The case is Patent Quality Assurance LLC v. VLSI Technology LLC, Patent Trial and Appeal Board, No.
Persons: Kathi Vidal, OpenSky, Benjamin Fernandez, Wilmer Cutler Pickering Hale, Dorr, Bruce Slayden, Slayden Grubert, Babak, Kenneth Weatherwax, Weatherwax Read, Blake Brittain Organizations: Intel, USPTO, U.S . Patent, Intel Corp, VLSI Technology, U.S ., Appeals, Federal Circuit, SoftBank Group Corp, Fortress Investment Group, Assurance, OpenSky Industries, Lowenstein, Tech, Thomson Locations: Texas, Delaware, Northern California, South Dakota, Washington
Senator Bernie Sanders, as well as Representatives Katie Porter and Pramila Jayapal also signed the letter. They expressed particular concern over Merck's efforts to patent a subcutaneous version of the currently infused drug, which Reuters reported on late last year. They wrote that Merck’s use of dozens of patents to fend off Keytruda competitors "appear(s) to be an example of the anti-competitive business practices ... that we have long beenconcerned about." Merck, which reported $20.9 billion in 2022 sales of Keytruda, has relied on the immunotherapy to fuel its growth. They urged Vidal to "give close scrutiny to any of Merck’s requests for new patents for Keytruda, and reject those that do not clearly meet the agency’s standards."
Total: 3